Seminar Series

Next full-series is scheduled to begin January 2020!

Please inform us who you (the recommender) is.

Please inform us about who you are recommending as a potential guest speaker.


Full Schedule for Spring 2020

Calendar icon Tuesday, April 07, 2020 | 10:30 am - 11:30 am March 10 at 3:00 pm | Online WebEx Meeting

From Bench to Clinic: Development of the 3M-052-Alum Vaccine Adjuvant Formulation

Christopher Fox

Christopher Fox

VP of Formulations at the Infectious Disease Research Institute

Abstract: For nearly a century, aluminum salts have been the most widely used vaccine adjuvant formulation, with an established history of safety and efficacy. Nevertheless, for extremely challenging disease targets such as tuberculosis or HIV, the adjuvant activity of aluminum salts is not adequate to achieve protective efficacy. This presentation will describe a formulation approach to solving this challenge by developing a lipid-based nanosuspension of a synthetic TLR7/8 ligand (3M-052), that facilitates adsorption to aluminum oxyhydroxide (Alum) via the structural properties of the lipid excipient employed.

WebEx Information:

 

Upcoming Speakers

Rebecca Gerth Ph.D.

Rebecca Gerth Ph.D.

Sales Engineer
Ripple Neuro

TBA

Going to the Dark Side - Choosing Industry

Susie Robertson

Susie Robinson

Evaluator WGU,
Online Biology Instructor UVU

Mar 30th

Cell Line Development for Drug Discovery Research and the Establishment of the BioProcessing - Demonstration and Training Lab at Utah State University

Special thanks to all of our previous presenters

Rob Franklin

Rob Franklin

Blackrock Microsytems

Tara Deans

Tara Deans

Assistant Professor
Biomedical Engineering,
University of Utah

Rahman Emamzadeh

Rahman Emamzadeh

Visiting Scholar

Libbie Linton

Libbie Linton M.S.

Assistant Unit leader,
Senior Process Engineer,
WesTech

Rachel Muller

Rachel Muller

Project Engineer
Merit Medical

Abraham Verdoes

Abraham Verdoes

BioEngineering Manager,
ELITechGroup

Ashley Farnsworth

Ashley Farnsworth

Merit Medical

Adam Brown

Adam Brown

Chief Executive Officer,
Quansys Biposciences

Issa Hamud

Issa Hamud

Enviromental Director,
City of Logan

Phil Heck

Phil Heck, Ph.D.

General Manager
Central Valley Water Reclamtion Facility

Chih-Hu Ho

Chih-Hu Ho, Ph.D.

Director of Biosciences
Global Research and Development

Justin Hyer, B.S.

Justin Hyer, B.S.

Sr. Development Engineer
OsteoCentric Technologies

Nephi Jones

Nephi Jones, M.S.

Senior R&D Manager
Advanced Technology Research, Thermo Fisher Scientific

Timothy A. Morgan

Timothy A. Morgan, Ph.D.

Scientist
Electro-Optic Technology Division Crane Division
Naval Surface Warfare Center (NSWC Crane)

Mark L. Nelson

Mark L. Nelson, Ph.D.

Vice President of Business and Science Development,
Frontier Scientific and Subsidiaries

Ray Olsen

Raymond E. Olsen

Adjunct Professional Practice Associate Professor,
Department of Animal Dairy and Veterinary Sciences, School of Veterinary Medicine, Utah State University
Adjunct Assistant Professor, Department of Orthopeadics,
University of Utah School of Medicine and VA Bone and Joint Laboratory

Daniel W. Odell

Daniel W. Odell, M.D.

Assistant Professor
Department of Anesthesiology, University of Utah
Supportive Oncology and Survivorship, Huntsman Cancer Hospital

William Pitt

Dr. William Pitt

Professor
Department of Chemical Engineering, Brigham Young Univrsity

Kamal A. Rashid

Kamal A. Rashid, Ph.D.

President, International Biotechnology Associates (IBA)

Dr. Matthew Weinstock

Dr. Matthew Weinstock

Group Leader, Molecular Sciences,
AbSci LLC